We evaluated the ENEA System, a fully automated instrument for the mea
surement of specific IgE antibodies. The instrument dispenses sera and
reagents, incubates, washes, and reads and prints results automatical
ly. The ''core'' of the instrument is the reactive unit called ACE (Al
lergy Chamber Enzymatic), which is a new solid phase to which the alle
rgens are linked. The system uses calibration curves specific for the
major allergen families, and data are supplied qualitatively (five cla
sses) and quantitatively. We evaluated the analytic efficiency of the
system and its correlation with the in vivo test (skin prick test (SPT
)) results in 60 patients with inhalant allergic diseases and in 20 co
ntrols. Results: 450 results were available within 4 h. A satisfactory
within-run (CVs between 1.58 and 6.2%) and between-run (CVs 6.3-11.5%
) precision was found. No significant carry-over was observed. A wide
linearity of the assay was demonstrated. With the concordance between
the clinical history and SPT as the reference value, the clinical sens
itivity of the ENEA System was 84.1%, the specificity 82.8%, and the o
verall efficiency 83.4%. Finally, a good agreement with the results of
another technique for the in vitro measurement of specific IgE (Pharm
acia CAP System) was proven.